Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Two-dimensional quantitative structure-activity relationship study of 1,4-naphthoquinone derivatives tested against HL-60 human promyelocytic leukaemia cells

Full text
Costa, M. C. A. ; Ferreira, M. M. C.
Total Authors: 2
Document type: Journal article
Source: SAR AND QSAR IN ENVIRONMENTAL RESEARCH; v. 28, n. 4, p. 325-339, 2017.
Web of Science Citations: 1

A series of 50 derivatives of 1,4-naphthoquinone tested against human HL-60 leukaemic cells showed activity at a wide range of concentrations. A multivariate quantitative structure-activity relationship (QSAR) study of 45 compounds was performed through principal component analysis (PCA) and partial least squares (PLS) regression. A good PLS regression model was obtained with two factors describing 60.1% of the total variance, and the selected descriptors were partial atomic charge at carbons 1 and 10 (C1 and C10) and total dipole moment (DIP). The calibration model exhibited the determination coefficient r(2) = 0.78 and the standard error of calibration = 0.29. For external validation, r(2) and the standard error of prediction were 0.74 and 0.32, respectively. DIP and C1 were the main descriptors for PCA, as well as for PLS, such that the pIC(50) value increases when C1 increases and DIP diminishes. The selected descriptors are in accordance with the literature, once C10 and C1 are bound or close to the quinone oxygens involved in the production of radical anions (O-2-.). From the QSAR analysis, the structures of two new naphthoquinones were proposed and their estimated IC50 values were 1.42 and 1.13 mol L-1. (AU)

FAPESP's process: 15/22951-2 - Theoretical Studies of bioactive substances Molecular modeling and QSAR (2D and 4D) studies of: A) 1,4 Naftoquinones derivatives with Antileucemic activity. B) Herbicides 3-benzil-5-arilidenofuran-2(5H)-one and Trifluoromethyl Arylamides
Grantee:Marcia Miguel Castro Ferreira
Support Opportunities: Regular Research Grants